ReviewTouchREVIEWS in endocrinology2023

Fezolinetant: A Potential Treatment for Moderate to Severe Vasomotor Symptoms of Menopause.

Barbara DePreePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.